Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorCHU de Reims
About this trial
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome.
The first stage of the study consisted in translating the questionnaire from English to French.
Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.
Eligibility criteria
Qualifiers
Women aged 18 to 45
Fluent in french
Having a diagnosis of PCOS according to the international recommendations published in 2023
Willing to participate in the study
Disqualifiers
Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder
Pregnancy or breast-feeding
Under legal protection
Trial design
Treatments tested in this trial
- mPCOSQ-F and SF-36
Treatment groups
350 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov